Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela F Hawk

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Obstetrics and Gynecology|February 21, 2012
Screening for fetal aneuploidy: is maternal age relevant?Angela F Hawk, Devereux N Saller
Prenatal Diagnosis|June 28, 2011
Genetic screening in a university clinic: impact of primary languageAngela F Hawk, Lisa Pastore, Devereux N Saller
Obstetrics and Gynecology|August 8, 2013
Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxisAngela F Hawk, Eugene Y Chang, Sally M Shields, et al.
Obstetrics and Gynecology|November 23, 2013
In replyAngela F Hawk, Eugene Y Chang, Sally M Shields, et al.
American Journal of Obstetrics and Gynecology|March 31, 2015
Diagnostic accuracy of fundal height and handheld ultrasound-measured abdominal circumference to screen for fetal growth abnormalitiesAdriane F Haragan, Thomas C Hulsey, Angela F Hawk, et al.
Hypertension in Pregnancy|July 3, 2014
Placental Nkx2-5 and target gene expression in early-onset and severe preeclampsiaElena R Rivers, Anthony J Horton, Angela F Hawk, et al.
American Journal of Obstetrics & Gynecology MFM|December 21, 2020
Performance of a proteomic preterm delivery predictor in a large independent prospective cohortGlenn R Markenson, George R Saade, Louise C Laurent, et al.
Journal of Medical Economics|November 15, 2022
Clinical and economic evaluation of a proteomic biomarker preterm birth risk predictor: cost-effectiveness modeling of prenatal interventions applied to predicted higher-risk pregnancies within a large and diverse cohortJulja Burchard, Glenn R Markenson, George R Saade, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Obstetrics and Gynecology|February 21, 2012
Screening for fetal aneuploidy: is maternal age relevant?Angela F Hawk, Devereux N Saller
Prenatal Diagnosis|June 28, 2011
Genetic screening in a university clinic: impact of primary languageAngela F Hawk, Lisa Pastore, Devereux N Saller
Obstetrics and Gynecology|August 8, 2013
Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxisAngela F Hawk, Eugene Y Chang, Sally M Shields, et al.
Obstetrics and Gynecology|November 23, 2013
In replyAngela F Hawk, Eugene Y Chang, Sally M Shields, et al.
American Journal of Obstetrics and Gynecology|March 31, 2015
Diagnostic accuracy of fundal height and handheld ultrasound-measured abdominal circumference to screen for fetal growth abnormalitiesAdriane F Haragan, Thomas C Hulsey, Angela F Hawk, et al.
Hypertension in Pregnancy|July 3, 2014
Placental Nkx2-5 and target gene expression in early-onset and severe preeclampsiaElena R Rivers, Anthony J Horton, Angela F Hawk, et al.
American Journal of Obstetrics & Gynecology MFM|December 21, 2020
Performance of a proteomic preterm delivery predictor in a large independent prospective cohortGlenn R Markenson, George R Saade, Louise C Laurent, et al.
Journal of Medical Economics|November 15, 2022
Clinical and economic evaluation of a proteomic biomarker preterm birth risk predictor: cost-effectiveness modeling of prenatal interventions applied to predicted higher-risk pregnancies within a large and diverse cohortJulja Burchard, Glenn R Markenson, George R Saade, et al.
Pageof 1